NEW TRIAL FOR URINARY BLADDER CANCER

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract (FORAGER-2)

NCT07218380

This is a STATE of the ART clinical trial for patients who have locally advanced or metastatic urinary bladder cancer that expresses a genetic mutation.

If you or anyone you know has urinary bladder cancer that is advanced or metastatic bladder cancer we will be happy to provide this state of the art cancer therapy REGARDLESS of the insurance status.